(a) For purposes of this subchapter- (1) The term "import" means, with respect to any article, any bringing in or introduction of such article into any area (whether or not such bringing in or introduction constitutes an importation within the meaning of the tariff laws of the United States). (2) The term "customs territory of the United States" has the meaning assigned to such term by general note 2 of the Harmonized Tariff Schedule of the United States. (b) Each term defined in section 802 of this
(a) Inventory Except as provided in subsection (c)- (1) every registrant under this subchapter shall, on May 1, 1971, or as soon thereafter as such registrant first engages in the manufacture, distribution, or dispensing of controlled substances, and every second year thereafter, make a complete and accurate record of all stocks thereof on hand, except that the regulations prescribed under this section shall permit each such biennial inventory (following the initial inventory required by this paragraph)
(a) For any registration issued under section 303 of the Act (21 U.S.C. 823 ), the Administrator may: (1) Suspend the registration pursuant to section 304(a) of the Act (21 U.S.C. 824(a) ) for any period of time. (2) Revoke the registration pursuant to section 304(a) of the Act (21 U.S.C. 824(a) ). (b) For any registration issued under section 1008 of the Act (21 U.S.C. 958 ), the Administrator may: (1) Suspend the registration pursuant to section 1008(d) of the Act (21 U.S.C. 958(d) ) for any period
(a) At any hearing on an application to manufacture any controlled substance listed in Schedule I or II, the applicant shall have the burden of proving that the requirements for such registration pursuant to section 303(a) of the Act (21 U.S.C. 823(a) ) are satisfied. Any other person participating in the hearing pursuant to § 1301.35(b) shall have the burden of proving any propositions of fact or law asserted by such person in the hearing. (b) At any hearing on the granting or denial of an applicant
(a)Reports generally. All reports required by this section shall be filed with the Pharmaceutical Investigations Section, Diversion Control Division, Drug Enforcement Administration on DEA Form 333, or on media which contains the data required by DEA Form 333 and which is acceptable to the Administration. See the Table of DEA Mailing Addresses in § 1321.01 of this chapter for the current mailing address. (b)Frequency of reports. Acquisition/Distribution transaction reports shall be filed every quarter